Kenvue tumbles after report RFK Jr. links autism risk in tylenol use

** Shares of consumer healthcare co Kenvue KVUE fall 10% to $18.46

** U.S. Health Secretary Robert F. Kennedy Jr. plans to release government report linking Tylenol use during pregnancy to autism, The Wall Street Journal reports, citing people familiar with matter

** Tylenol, whose active ingredient is acetaminophen, is made by Kenvue and is widely used for pain relief, including by pregnant women

** Report will also suggest medicine derived from folate, called folinic acid, can be used to treat symptoms of the disorder in some people, WSJ adds

** Speaking on WSJ report, Kenvue says it continues to believe there is no causal link between acetaminophen use during pregnancy and autism, CNBC reports

** Including session's moves, stock down 12% YTD